Study title: Efficacy and Safety by Children and Adolescents (5-17 yrs and 2 months) with Autictic Disorders
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Mental Disorders | |||||
| Brands: | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: TRETINOIN | |||||
| ATC code: N05AX08 | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: RIS-USA-150 | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | - | |